Clinical Trials Directory

Trials / Unknown

UnknownNCT05121610

Effects of Different Revascularization StrateGies in Complex Coronary Artery DiseasE (EDGE)

Effects of Different Revascularization Strategies on Cardiovascular Outcomes in Patients With Complex Coronary Artery Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
2,864 (estimated)
Sponsor
Beijing Anzhen Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Coronary heart disease is one of the most serious diseases that endanger people's health. Complex coronary artery disease is critical and has high mortality. Therefore, it is urgent to explore the best treatment method for complex coronary artery disease. Some previous studies have shown that patients with left main coronary artery disease with a SYNTAX score\> 32 points, and diabetic/non-diabetic three-vessel disease patients with coronary heart disease with a SYNTAX score \> 22 points, CABG is recommended for revascularization. However, with the continuous innovation of surgical technology and the rapid development of surgical instruments, the treatment of patients with complex coronary artery disease is increasing. Therefore, it is necessary to investigate the effects of different revascularization strategies on long-term prognosis in patients with complex coronary artery disease (SYNTAX score \> 22 points).

Conditions

Interventions

TypeNameDescription
PROCEDUREThe procedures include PCI, CABG and HCRThe procedures include PCI, CABG and HCR

Timeline

Start date
2021-12-01
Primary completion
2022-09-01
Completion
2023-09-01
First posted
2021-11-16
Last updated
2021-11-16

Source: ClinicalTrials.gov record NCT05121610. Inclusion in this directory is not an endorsement.